{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "from Bio import Entrez\n",
    "\n",
    "def search(query):\n",
    "    Entrez.email = 'ekanoulas@gmail.com'\n",
    "    handle = Entrez.esearch(db='pubmed', \n",
    "                            sort='relevance', \n",
    "                            retmax='20',\n",
    "                            retmode='xml', \n",
    "                            term=query)\n",
    "    results = Entrez.read(handle)\n",
    "    return results\n",
    "\n",
    "def fetch_details(id_list):\n",
    "    ids = ','.join(id_list)\n",
    "    Entrez.email = 'ekanoulas@gmail.com'\n",
    "    handle = Entrez.efetch(db='pubmed',\n",
    "                           retmode='xml',\n",
    "                           id=ids)\n",
    "    results = Entrez.read(handle)\n",
    "    return results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "import csv\n",
    "from googleapiclient.discovery import build\n",
    "import editdistance\n",
    "\n",
    "\n",
    "key = 'AIzaSyBCuZQf23FpIqsalPEUeXPembFc5od2wYU'\n",
    "searchid = '011307515825205873396:4lqumakuprq'\n",
    "\n",
    "service = build(\"customsearch\", \"v1\", developerKey=key)\n",
    "\n",
    "with open('/Users/ekanou/CLEF/tar/2018-TAR/Task1/Testing/qrels/CD008587.csv', 'r') as csvfile:\n",
    "    reader = csv.reader(csvfile)\n",
    "    for row in reader:\n",
    "        if row[1]==\"additional\":break\n",
    "            \n",
    "        parts = row[0].split('.')\n",
    "        if (len(parts)>1): #if missing pubmed id\n",
    "            query = parts[1].lstrip() + '.'\n",
    "            \n",
    "            # Search Google\n",
    "            res = service.cse().list(q=query,cx=searchid,num=1).execute()\n",
    "            if 'items' in res.keys():\n",
    "                link = res['items'][0]['link']\n",
    "                url = link.split('/')\n",
    "                if len(url)>4:\n",
    "                    if ('pagemap' in res['items'][0] and 'citation_title' in res['items'][0]['pagemap']['metatags'][0]):\n",
    "                        title = res['items'][0]['pagemap']['metatags'][0]['citation_title']\n",
    "                        if editdistance.eval(query.lower(),title.lower()) < 4:\n",
    "                            print(url[4] + ',' + row[1] + ',' + row[2])\n",
    "                        elif editdistance.eval(query.lower(),title.lower()) < 20 or row[1]==\"included\":\n",
    "                            print(\"query\")\n",
    "                            print(query)\n",
    "                            print(title)\n",
    "                    else:\n",
    "                        print(\"query\")\n",
    "                        print(query)\n",
    "                        print(\"No title available\")\n",
    "                \n",
    "        else:\n",
    "            print(row[0] + ',' + row[1] + ',' + row[2])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "from os import listdir\n",
    "from os.path import isfile, join\n",
    "mypath = '/Users/ekanou/CLEF/tar/2018-TAR/Task1/Testing/qrels-new/'\n",
    "onlyfiles = [f for f in listdir(mypath) if isfile(join(mypath, f))]\n",
    "print(onlyfiles)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "for file in onlyfiles:\n",
    "    if file != '.DS_Store':\n",
    "        print(join(mypath, file))\n",
    "        lines_seen = set() # holds lines already seen\n",
    "        outfile = open(file, \"w\")\n",
    "        for line in open(join(mypath, file), \"r\"):\n",
    "            if line not in lines_seen: # not a duplicate\n",
    "                outfile.write(line)\n",
    "                lines_seen.add(line)\n",
    "        outfile.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "import os \n",
    "cwd = os.getcwd()\n",
    "print(cwd)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true,
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CD010864\n",
      "\n",
      "\n",
      "To investigate the ability of the D-dimer test to rule out a diagnosis of acute PE in patients treated in hospital outpatient and accident and emergency (A&E) settings who have had a pre-test probability (PTP) of PE determined according to a clinical prediction rule (CPR), by estimating the accuracy of the test according to estimates of sensitivity and specificity. The review focuses on those patients who are not already established on anticoagulation at the time of study recruitment.\n",
      "Secondary objectives\n",
      "To investigate the following as potential sources of heterogeneity: age, sex, previous PE, prolonged immobilisation and type of reference standard. We recognise that all of these listed items except type of reference standard are patient-specific rather than study-specific, and we anticipate that study reports may lack the necessary level of detail to enable an informative analysis.\n",
      "\n",
      "\n",
      "To investigate the ability of the D‐dimer test to rule out a diagnosis of acute PE in patients treated in hospital outpatient and accident and emergency (A&E) settings who have had a pre‐test probability (PTP) of PE determined according to a clinical prediction rule (CPR), by estimating the accuracy of the test according to estimates of sensitivity and specificity. The review focuses on those patients who are not already established on anticoagulation at the time of study recruitment.\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "CD011420\n",
      "\n",
      "\n",
      "Primary objectives\n",
      "To assess the accuracy of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis (TB) disease in HIV-positive adults who have signs and symptoms suggestive of TB.\n",
      "To assess the accuracy of the LF-LAM as a screening test for active TB disease in HIV-positive adults irrespective of signs and symptoms suggestive of TB.\n",
      "Secondary objectives\n",
      "To compare the diagnostic accuracy of LF-LAM and existing tests, sputum smear microscopy or sputum Xpert® MTB/RIF, as well as determine the diagnostic accuracy of LF-LAM when added to existing tests.\n",
      "To investigate heterogeneity of test accuracy in the included studies. Possible sources of heterogeneity include CD4 count and clinical setting (inpatient versus outpatient setting).\n",
      "\n",
      "\n",
      "To assess the accuracy of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis (TB) disease in HIV-positive adults who have signs and symptoms suggestive of TB.To assess the accuracy of the LF-LAM as a screening test for active TB disease in HIV-positive adults irrespective of signs and symptoms suggestive of TB.\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "CD009263\n",
      "\n",
      "\n",
      "We reviewed three index test combinations: 1. ¹²³I-MIBG scintigraphy, 2. 18F-FDG-PET(-CT), and 3. ¹²³I-MIBG scintigraphy plus 18F-FDG-PET(-CT). See Figure 1: flowchart of index tests.\n",
      "Figure 1.\n",
      "Open in figure viewerDownload Powerpoint slide\n",
      "Flow chart index tests in patients with suspected neuroblastoma.\n",
      "Primary objective \n",
      "1.1 To determine the diagnostic accuracy of ¹²³I-MIBG (SPECT-CT) scintigraphy for detecting a neuroblastoma and its metastases at first diagnosis or at recurrence in children from 0 to 18 years old.\n",
      "1.2 To determine the diagnostic accuracy of negative ¹²³I-MIBG scintigraphy in combination with 18F-FDG-PET(-CT) imaging for detecting a neuroblastoma and its metastases at first diagnosis or at recurrence in children from 0 to 18 years old. In this case 18F-FDG-PET(-CT) is an add-on test.\n",
      "Secondary objectives\n",
      "2.1 To determine the diagnostic accuracy of 18F-FDG-PET(-CT) imaging for detecting a neuroblastoma and its metastases at first diagnosis or at recurrence in children from 0 to 18 years old.\n",
      "2.2 To compare the diagnostic accuracy of ¹²³I-MIBG (SPECT-CT) scintigraphy and of 18F-FDG-PET(-CT) imaging for detecting a neuroblastoma and its metastases at first diagnosis or at recurrence in children from 0 to 18 years old. This was performed within and between (objective 1.1 compared to objective 2.1) included studies. ¹²³I-MIBG (SPECT-CT) scintigraphy was the comparator test in this case.\n",
      "Investigation of sources of heterogeneity\n",
      "When assessing study results, we considered methodological and clinical sources of heterogeneity as well as variation in the criteria used to define a positive test result. Several factors may contribute to heterogeneity in diagnostic performance across studies. We investigated, where possible, the potential influence of differences in the following items:\n",
      "Study population:\n",
      "Newly diagnosed versus recurrent neuroblastoma.\n",
      "Stage of disease (1 to 4 and 4S) as an ordinal variable. We reported stage 1 and 2 combined and stage 3, 4 and 4S separately.\n",
      "Index test radio labelled MIBG (SPECT-CT) scintigraphy:\n",
      "Time span between injection and scanning (24 or 48 hours) (acquisition time).\n",
      "WB scan versus SPECT-CT.\n",
      "Interfering medication (Table 3).\n",
      "Reference standard:\n",
      "Type of test: histopathology (reference test 1) versus bone marrow aspirate or trephine biopsy (reference test 2) versus histopathology in combination with excretion of catecholamines in the urine and additional imaging modalities (reference test 3).\n",
      "\n",
      "\n",
      "To determine the diagnostic accuracy of 123I-MIBG (SPECT-CT) scintigraphy for detecting a primary or recurrent neuroblastoma tumour and its metastases in children from 0 to 18 years old.To determine the diagnostic accuracy of negative 123I-MIBG scintigraphy in combination with 18F-FDG-PET(-CT) imaging for detecting a primary or recurrent neuroblastoma tumour and its metastases in children from 0 to 18 years old. In this case 18F-FDG-PET(-CT) is an add-on test.\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "CD011431\n",
      "\n",
      "\n",
      "To assess the diagnostic accuracy of RDTs for detecting non-falciparum or P. vivax malaria parasitaemia in people living in malaria-endemic areas who present to ambulatory healthcare facilities with symptoms suggestive of malaria and to identify which types and brands of commercial test best detect non-falciparum and P. vivax malaria.\n",
      "Investigation of sources of heterogeneity\n",
      "We planned to investigate heterogeneity in relation to age group, continent where the study took place, and adequacy of reference standard.\n",
      "\n",
      "\n",
      "To assess the diagnostic accuracy of RDTs for detecting non-falciparum or P. vivax parasitaemia in people living in malaria-endemic areas who present to ambulatory healthcare facilities with symptoms suggestive of malaria, and to identify which types and brands of commercial test best detect non-falciparum and P. vivax malaria.\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "CD011686\n",
      "\n",
      "\n",
      "To determine the diagnostic accuracy of the NEXUS criteria and the Canadian C-spine Rule in a pediatric population evaluated for CSI following blunt trauma.\n",
      "Secondary objectives\n",
      "We expected to observe heterogeneity in the estimates of diagnostic accuracy. Factors that may contribute to heterogeneous results include:\n",
      "Differences in the healthcare setting and study design; previous studies state that CSI is seen less often in general emergency departments than in pediatric trauma hospitals, and that a CT of the neck is more common in general emergency departments (Adelgais 2014).\n",
      "Study quality, as assessed by the QUADAS-2 checklist (Whiting 2011).\n",
      "Age-related differences; we expect that both the applicability of the NEXUS criteria and the Canadian C-spine Rule and the type of injury will differ according to age in children younger and older than eight (Leonard 2013; Leonard 2014).\n",
      "\n",
      "\n",
      "This review aims to determine the diagnostic accuracy of the NEXUS criteria and the Canadian C-spine rule in a pediatric population evaluated for CSI following blunt trauma.\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "CD012179\n",
      "\n",
      "\n",
      "Primary objectives\n",
      "To evaluate blood biomarkers as replacement tests for diagnostic surgery and as triage tests to inform decisions to undertake surgery for endometriosis. Specific objectives include the following.\n",
      "To provide summary estimates of the diagnostic accuracy of blood biomarkers for the diagnosis of peritoneal, ovarian and deep infiltrating pelvic endometriosis, compared to surgical diagnosis as a reference standard.\n",
      "To assess the diagnostic utility of biomarkers that could differentiate ovarian endometrioma from other ovarian masses.\n",
      "Secondary objectives\n",
      "To investigate the influence of heterogeneity on the diagnostic accuracy of blood biomarkers for endometriosis. Potential sources of heterogeneity include:\n",
      "participant characteristics: age (adolescents versus later reproductive years), clinical presentation (subfertility, pelvic pain, ovarian mass, asymptomatic women), stage of disease (rASRM classification system), geographic location of study;\n",
      "histological confirmation in conjunction with laparoscopic visualisation compared to laparoscopic visualisation alone;\n",
      "changes in technology over time: year of publication, modifications applied to conventional laboratory techniques;\n",
      "methodological quality: differences in the revised Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) evaluation (Table 3), including low versus unclear or high risk; consecutive versus non-consecutive enrolment; and blinding of surgeons to the results of index tests;\n",
      "Table 3. Application of the QUADAS-2 tool for assessment of methodological quality of the included studies\n",
      "Domain 1 - Patient selection  \n",
      "Description Describe methods of patient selection and included patients  \n",
      "Type of bias assessed Selection bias, spectrum bias  \n",
      "Review Question Women of reproductive age with clinically suspected endometriosis (symptoms, clinical examination ± presence of pelvic mass), scheduled for surgical exploration of pelvic/abdominal cavity for confirmation of the diagnosis ± treatment  \n",
      "Informaton collected Study objectives, study population, selection (inclusion/exclusion criteria), study design, clinical presentation, age, number of enrolled and number of available for analysis, setting, place and period of the study  \n",
      "Signalling question 1 Was a consecutive or random sample of patients enrolled?  \n",
      "Yes If a consecutive sample or a random sample of the eligible participants was included in the study  \n",
      "No If a consecutive sample or a random sample of the eligible participants was not included in the study  \n",
      "Unclear If this information was unclear  \n",
      "Signalling question 2 Did the study avoid inappropriate exclusions?  \n",
      "Yes If inclusion and exclusion criteria were presented and all participants with suspected endometriosis were included, with an exception for those who either had a history of medical conditions or were on medical therapy that would have potentially interfered with interpretation of index test (e.g. malignancy, pregnancy, autoimmune disorders, infectious diseases, treatment with hormonal or immunomodulator substances); refused to participate in the study; or were unfit for surgery  \n",
      "No If the study excluded the participants based on education level, psychosocial factors, genetic testing or phenotype or excluded participants with any comorbidities commonly present in general population, including a population that could have undergone a testing for endometriosis in clinical setting (hypertension, asthma, obesity, benign gastrointestinal or renal disease, etc)  \n",
      "Unclear If the study did not provide clear definition of the selection (inclusion/exclusion) criteria and 'no' judgement was not applicable  \n",
      "Signalling question 3 Was a 'two-gate' design avoided?  \n",
      "Yes If the study had a single set of inclusion criteria, defined by the clinical presentation (i.e. only participants in whom the target condition is suspected) - a single-gate design  \n",
      "No If the study had more than one set of inclusion criteria in respect to clinical presentation (i.e. participants suspected of target condition and participants with alternative diagnosis in whom the target condition would not be suspected in clinical practice) - a two-gate study design  \n",
      "Unclear If it was unclear whether a two-gate deign was avoided or not  \n",
      "Risk of bias Could the selection of patients have introduced bias?  \n",
      "Low If 'yes' classification for all the above 3 questions  \n",
      "High If 'no' classification for any of the above 3 questions  \n",
      "Unclear If 'unclear' classification for any of the above 3 questions and 'high risk' judgement was not applicable  \n",
      "Concerns about applicability Are there concerns that the included patients do not match the review question?  \n",
      "Low If the study includes only clinically relevant population that would have undergone index test in real practice and includes representative form of target condition  \n",
      "High If the study population differed from the population defined in the review question in terms of demographic features and comorbidity (e.g. studies with multiple sets of inclusion criteria with respect to clinical presentation including either healthy controls or alternative diagnosis controls that would not have undergone index test in real practice). Further, if target condition diagnosed in the study population was not representative of the entire spectrum of disease, such as limited spectrum of severity (e.g. only mild forms) or limited type of endometriosis (e.g. only deep infiltrating endometriosis)  \n",
      "Unclear If this information was unclear (e.g. severity of endometriosis was not reported)  \n",
      "Domain 2 - Index test  \n",
      "Description Describe the index test, how it was conducted and interpreted  \n",
      "Type of bias assessed Test review bias, clinical review bias, interobserver variation bias  \n",
      "Review question Any type of blood-based biomarker  \n",
      "Informaton collected Index test name, description of positive case definition by index test as reported, threshold for positive result, examiners (number, level of expertise, blinding), interobserver variability, conflict of interests  \n",
      "Signalling question 1 Were the index test results interpreted without knowledge of the results of the reference standard?  \n",
      "Yes If the operators performing/interpreting index test were unaware of the results of the reference standard  \n",
      "No If the operators performing/interpreting index test were not blinded to the results of the reference standard  \n",
      "Unclear If this information was unclear  \n",
      "Signalling question 2 If a threshold was used, was it pre-specified?  \n",
      "Yes If study clearly provided a threshold for positive result and was defined before execution/interpretation of index test  \n",
      "No If a threshold for positive result was not provided or not defined prior to test execution  \n",
      "Unclear If it was unclear whether a threshold was pre-specified or not  \n",
      "Signalling question 3 Was a menstrual cycle phase considered in interpreting the index test?  \n",
      "Yes If all the included participants were in the same phase of menstrual cycle, if the study reported subgroup analyses per cycle phase, or if study reported the pooled estimates after impact of the cycle phase on biomarker expression was not detected  \n",
      "No If study included participants in different phases of menstrual cycle, but effect of cycle phase on index test was not assessed  \n",
      "Unclear If the cycle phase was not reported  \n",
      "Risk of bias Could the conduct or interpretation of the index test have introduced bias?  \n",
      "Low If 'yes' classification for all the above 3 questions  \n",
      "High If 'no' classification for any of the above 3 questions  \n",
      "Unclear If 'unclear' classification for any of the above 3 questions and 'high risk' judgement was not applicable  \n",
      "Concerns about applicability Are there concerns that the index test, its conduct, or interpretation differ from the review question?  \n",
      "Low We considered all types of blood-based biomarkers as eligible, therefore all the included studies were classified as 'low concern', unless 'unclear' judgement was applicable  \n",
      "High We did not consider the studies where index tests other than blood-based biomarkers were included (or excluded information on other index tests reported in addition to blood tests) or where index test looked at other target conditions not specified in the review (e.g. studies aimed at classifying pelvic masses as benign and malignant); therefore none of the included studies was classified as 'high concern'  \n",
      "Unclear If study reported, but did not present sufficient information on any of the following: laboratory method, sample handling, reagents used or experience of the test operators  \n",
      "Domain 3 - Reference standard  \n",
      "Description Describe the reference standard, how it was conducted and interpreted  \n",
      "Type of bias assessed Verification bias, bias in estimation of diagnostic accuracy due to inadequate reference standard  \n",
      "Review question Target condition - pelvic endometriosis, ovarian endometriosis, deep infiltrating endometriosis. Reference standard - visualisation of endometriosis at surgery (laparoscopy or laparotomy) with or without histological confirmation  \n",
      "Informaton collected Target condition, prevalence of target condition in the sample, reference standard, description of positive case definition by reference test as reported, examiners (number, level of expertise, blinding), interobserver variability, conflict of interests  \n",
      "Signalling question 1 Is the reference standard likely to correctly classify the target condition?  \n",
      "Yes If the study reported at least one of the following: surgical procedure was described in sufficient detail; criteria for positive reference standard were stated; diagnosis was confirmed by histopathology; or the procedure was performed by a team with high level of expertise in diagnosis/surgical treatment of target condition, including tertiary referral centres for endometriosis  \n",
      "No If reference standard did not classify target condition correctly; considering the inclusion criteria and nature of the reference standard, none of the studies were classified as 'no' for this item  \n",
      "Unclear If information on execution of the reference standard, its interpretation or operators was unclear  \n",
      "Signalling question 2 Were the reference standard results interpreted without knowledge of the results of the index tests?  \n",
      "Yes If operators performing the reference test were unaware of the results of the index test  \n",
      "No If operators performing the reference test were aware of the results of the index test  \n",
      "Unclear If this information was unclear  \n",
      "Risk of bias Could the reference standard, its conduct, or its interpretation have introduced bias?  \n",
      "Low If 'yes' classification for both of the above 2 questions  \n",
      "High If 'no' classification for any of the above 2 questions  \n",
      "Unclear If 'unclear' classification for any of the above 2 questions and 'high risk' judgement was not applicable  \n",
      "Concerns about applicability Are there concerns that the target condition as defined by the reference standard does not match the question?  \n",
      "Low Considering the inclusion criteria, all the studies were classified as 'low concern', unless 'unclear' judgement was applicable  \n",
      "High We excluded the studies where participants did not undergo surgery for diagnosis of endometriosis; therefore none of the included studies were classified as 'high concern'  \n",
      "Unclear Only studies where laparoscopy/laparotomy served as a reference test were included; therefore none of the included studies were classified as 'unclear concern'  \n",
      "Domain 4 - Flow and timing  \n",
      "Description Describe any participants who did not receive the index tests or reference standard or who were excluded from the 2 x 2 table; describe the interval and any interventions between index tests (sample collection) and the reference standard  \n",
      "Type of bias assessed Disease progression bias, bias of diagnostic performance due to missing data  \n",
      "Review question Less than 12-month interval between index test (sample collection) and reference standard - endometriosis may progress over the time, so we had chosen an arbitrary time interval of 12 months as an acceptable time interval between the index test and surgical confirmation of diagnosis  \n",
      "Informaton collected Time interval between index test (sample collection) and reference standard, withdrawals (overall number of reported and if explanation)  \n",
      "Signalling question 1 Was there an appropriate interval between index test (sample collection) and reference standard?  \n",
      "Yes If time interval was reported and was less than 12 months  \n",
      "No We excluded all the studies where time interval was longer than 12 months; therefore none of the included studies were classified as 'no' for this item  \n",
      "Unclear If time interval was not stated clearly, but authors description allowed us to assume that the interval was reasonably short  \n",
      "Signalling question 2 Did all patients receive the same reference standard?  \n",
      "Yes If all participants underwent laparoscopy/laparotomy as a reference standard. Considering the inclusion criteria, all the studies were classified as 'yes' for this item, as anticipated  \n",
      "No If all participants did not undergo surgery or had alternative reference standard or if only a subset of participants had surgery as reference standard, but the information on this population was not available in isolation  \n",
      "Unclear If this information was unclear. Considering the inclusion criteria, none of the included studies were classified as 'unclear' for this item  \n",
      "Signalling question 3 Were all patients included in the analysis?  \n",
      "Yes If all the participants were included in the analysis or if the participants were excluded because they did not meet inclusion criteria prior to execution of index test or if the withdrawals were less than 5% of the enrolled population (arbitrary selected cut-off)  \n",
      "No If any participants were excluded from the analysis because of uninterpretable results, inability to undergo either index test or reference standard, or unclear reasons  \n",
      "Unclear If this information was unclear  \n",
      "Risk of bias Could the patient flow have introduced bias?  \n",
      "Low If 'yes' classification for all the above 3 questions  \n",
      "High If 'no' classification for any of the above 3 questions  \n",
      "Unclear If 'unclear' classification for any of the above 3 questions and 'high risk' judgement was not applicable  \n",
      "study design (single-gate design versus two-gate design studies).\n",
      "To assess biomarkers that were not affected by endometriosis and hence were unlikely to discriminate between women with and without the disease.\n",
      "\n",
      "\n",
      "To evaluate blood biomarkers as replacement tests for diagnostic surgery and as triage tests to inform decisions to undertake surgery for endometriosis. Specific objectives include the following. To provide summary estimates of the diagnostic accuracy of blood biomarkers for the diagnosis of peritoneal, ovarian and deep infiltrating pelvic endometriosis, compared to surgical diagnosis as a reference standard. To assess the diagnostic utility of biomarkers that could differentiate ovarian endometrioma from other ovarian masses.\n",
      "\n",
      "\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "from os import listdir\n",
    "from os.path import isfile, join\n",
    "import xmltodict\n",
    "\n",
    "mypath = '/Users/ekanou/CLEF/tar/2018-TAR/Task1/Testing/topics/'\n",
    "mypath2 = '/Users/ekanou/CLEF/tar/2018-TAR/Task1/Testing/protocols/'\n",
    "\n",
    "onlyfiles = [f for f in listdir(mypath) if isfile(join(mypath, f))]\n",
    "\n",
    "for file in onlyfiles:\n",
    "    if file != '.DS_Store':\n",
    "        with open(join(mypath2, file)) as fd:\n",
    "            doc = xmltodict.parse(fd.read())\n",
    "            proto = doc['root']['objective']\n",
    "            \n",
    "        objective = False\n",
    "        for line in open(join(mypath, file), \"r\"):\n",
    "            if 'Objectives:' in line: # not a duplicate\n",
    "                (obj, text) = line.split(':',1)\n",
    "                objective = True\n",
    "            else:\n",
    "                if objective:\n",
    "                    text = text + line\n",
    "        topic = text.lstrip().rstrip()\n",
    "        if topic not in proto:\n",
    "            print(file)\n",
    "            print('\\n')\n",
    "            print(proto)\n",
    "            print('\\n')\n",
    "            print(topic)\n",
    "            print('\\n')\n",
    "            print('\\n')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
